Publications by authors named "Eva Villaron"

Claim this Profile
E
Effect of Hyaluronic Acid Compared to Platelet-Rich Plasma as Adjuvants to Bone Marrow Mesenchymal Stem Cell Treatment of Knee Osteoarthritis: Analysis from Two Clinical Trials.
José María Lamo-Espinosa, Álvaro Suárez-López Del Amo, Jorge María Núñez-Córdoba, Juan F Blanco, Mikel Sánchez

Diagnostics (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells.
Almudena Navarro-Bailón, Miriam López-Parra, Álvaro Veiga-Vaz, Eva María Villarón, María Díez-Campelo

Cytotherapy· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous mesenchymal stromal cells embedded with Tissucol Duo for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up.
Marcelo F Jiménez, María Teresa Gómez-Hernández, Eva M Villarón, Miriam López-Parra, Fermín Sánchez-Guijo

Stem Cell Res Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial.
Victoria Gomez-Ruiz, Juan F Blanco, Eva M Villarón, Helena Fidalgo, Miriam López-Parra

Stem Cell Res Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis.
Juan F Blanco, Francisco J Garcia-Garcia, Eva M Villarón, Carmen da Casa, Helena Fidalgo

J Clin Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.
Maria Eugenia Fernández-Santos, Mariano Garcia-Arranz, Enrique J Andreu, Ana Maria García-Hernández, Miriam López-Parra

Front Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).
Barbara Soria-Juan, Mariano Garcia-Arranz, Lucía Llanos Jiménez, César Aparicio, Alejandro Gonzalez

Trials· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial.
Arantza Campo, José María González-Ruiz, Enrique Andreu, Ana B Alcaide, María M Ocón, Eva Villaron

ERJ Open Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up.
Juan F Blanco, Eva M Villarón, David Pescador, Carmen da Casa, Victoria Gómez

Stem Cell Res Ther· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II).
José María Lamo-Espinosa, Gonzalo Mora, Juan F Blanco, Froilán Granero-Moltó, Jorge María Núñez-Córdoba

J Transl Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease).
Jorge D Martin-Rufino, Francisco S Lozano, Alba M Redondo, Eva M Villaron, Raquel Rueda

Stem Cell Res Ther· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).
José M Lamo-Espinosa, Gonzalo Mora, Juan F Blanco, Froilán Granero-Moltó, Jorge M Nuñez-Córdoba

J Transl Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.
Fermín Sánchez-Guijo, Teresa Caballero-Velázquez, Olga López-Villar, Alba Redondo, Rocío Parody, Eva Villaron

Biol Blood Marrow Transplant· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation.
Fermin M Sánchez-Guijo, Olga López-Villar, Lucía López-Anglada, Eva M Villarón, Sandra Muntión

Transfusion· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective comparative analysis of the angiogenic capacity of monocytes and CD133+ cells in a murine model of hind limb ischemia.
Natalia López-Holgado, Mercedes Alberca, Fermin Martin Sánchez-Guijo, Eva Maria Villarón, Jose Vicente Rivas

Cytotherapy· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification.
Soraya Carrancio, Natalia López-Holgado, Fermín M Sánchez-Guijo, Eva Villarón, Victoria Barbado

Exp Hematol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines.
Belén Blanco, José A Pérez-Simón, Luis I Sánchez-Abarca, Xonia Carvajal-Vergara, Juan Mateos

Blood· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation.
Eva M Villaron, Jose Antonio Perez-Simon, Jesus F San Miguel, Consuelo del Cañizo

Exp Hematol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability.
Fermin M Sanchez-Guijo, Luis-Ignacio Sanchez-Abarca, Eva Villaron, Natalia Lopez-Holgado, Mercedes Alberca

Exp Hematol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors.
Fermin M Sanchez-Guijo, Luis-Ignacio Sanchez-Abarca, Clara Bueno, Eva Villaron, Natalia Lopez-Holgado

Biol Blood Marrow Transplant· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors.
Natalia López-Holgado, Carmen Pata, Eva Villarón, Fermín Sánchez-Guijo, Mercedes Alberca

Haematologica· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.
Eva María Villaron, Julia Almeida, Natalia López-Holgado, Miguel Alcoceba, Luis Ignacio Sánchez-Abarca

Haematologica· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of hematopoietic progenitor cells in patients with myelodysplastic syndromes according to their cytogenetic abnormalities.
Natalia López-Holgado, Jose Luis Arroyo, Carmen Pata, Eva Villarón, Fermín Sánchez Guijo

Leuk Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunophenotypic analysis of myelodysplastic syndromes.
M Consuelo Del Cañizo, M Eugenia Fernández, Antonio López, Belén Vidriales, Eva Villarón

Haematologica· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis